Hookipa PharmaHOOK
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 34 institutions reported holding Hookipa Pharma Inc. (HOOK) in their 13F filings, up 32 from Q2 2024. 8 opened new positions and 0 sold out. The largest holders were Baker Bros. Advisors LP ($3.5M), EcoR1 Capital, LLC ($2.5M) and Siren, L.L.C. ($2.4M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Hookipa Pharma Inc.
- CUSIP
- 43906K209
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $536K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 140,811 shares bought and 7,351,434 shares sold, net −7,210,623 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Baker Bros. Advisors LP | 0.04% | Reduce -90.0% | 812,814 | $3.5M |
| EcoR1 Capital, LLC | 0.08% | No change | 571,727 | $2.5M |
| Siren, L.L.C. | 0.12% | — | 566,640 | $2.4M |
| FMR LLC | 0.00% | Add +0.3% | 341,476 | $1.5M |
| Vanguard Group Inc. | 0.00% | Add +0.6% | 213,222 | $917K |
| Redmile Group, LLC | 0.03% | No change | 106,376 | $457K |
| Acadian Asset Management LLC | 0.00% | Reduce -14.3% | 84,885 | $364K |
| Geode Capital Management, LLC | 0.00% | Add +2.7% | 72,679 | $313K |
| Ikarian Capital, LLC | 0.07% | New | 53,076 | $228K |
| Dimensional Fund Advisors LP | 0.00% | New | 48,635 | $209K |
| Renaissance Technologies | 0.00% | Add +4.1% | 31,470 | $135K |
| Royal Bank of Canada | 0.00% | Add +9.7% | 23,630 | $102K |
| State Street Corp. | 0.00% | No change | 16,967 | $73K |
| Gsa Capital Partners LLP | 0.01% | Add +38.8% | 16,609 | $71K |
| Northern Trust Corp. | 0.00% | No change | 15,661 | $67K |
| BlackRock, Inc. | 0.00% | — | 12,250 | $53K |
| Boothbay Fund Management, LLC | 0.00% | New | 11,768 | $51K |
| Citadel Advisors | 0.00% | New | 11,173 | $48K |
| Morgan Stanley | 0.00% | Reduce -68.5% | 7,441 | $32K |
| Group One Trading LLC | 0.00% | Reduce -37.6% | 3,679 | $16K |
| UBS Group AG | 0.00% | Add +46665.6% | 2,993 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -74.7% | 1,078 | $5K |
| JPMorgan Chase & Co. | 0.00% | Add +63328.6% | 888 | $4K |
| Bank of America Corp. | 0.00% | Add +3.3% | 566 | $2K |
| Lanark Financial, Inc. | 0.00% | No change | 600 | $2K |
| Parallel Advisors, LLC | 0.00% | Reduce -90.0% | 35 | $151 |
| Wells Fargo & Company | 0.00% | New | 33 | $142 |
| BNP Paribas Financial Markets | 0.00% | Reduce -2.1% | 33 | $142 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 33 | $142 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 8 | $34 |
| Bokf, NA | 0.00% | New | 8 | $33 |
| Citigroup Inc. | 0.00% | Reduce -5.4% | 7 | $30 |
| Truvestments Capital LLC | 0.00% | New | 2 | $9 |
| Lazard Asset Management LLC | 0.00% | Add +74.5% | 218 | $0 |
"% of holder's portfolio" is HOOK's weight in each manager's 13F, not the share of Hookipa Pharma Inc. the manager owns.